SARTORIUS AG (SRT.DE) Stock Fundamental Analysis

FRA:SRT • DE0007165607

191.5 EUR
+1.5 (+0.79%)
Last: Feb 19, 2026, 09:54 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall SRT gets a fundamental rating of 2 out of 10. We evaluated SRT against 18 industry peers in the Life Sciences Tools & Services industry. SRT may be in some trouble as it scores bad on both profitability and health. SRT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • SRT had positive earnings in the past year.
  • SRT had a positive operating cash flow in the past year.
  • SRT had positive earnings in 4 of the past 5 years.
  • Of the past 5 years SRT 4 years had a positive operating cash flow.
SRT.DE Yearly Net Income VS EBIT VS OCF VS FCFSRT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • SRT's Return On Assets of 1.39% is on the low side compared to the rest of the industry. SRT is outperformed by 72.22% of its industry peers.
  • SRT has a Return On Equity of 5.01%. This is in the lower half of the industry: SRT underperforms 66.67% of its industry peers.
  • SRT's Return On Invested Capital of 4.71% is on the low side compared to the rest of the industry. SRT is outperformed by 72.22% of its industry peers.
  • SRT had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 9.81%.
Industry RankSector Rank
ROA 1.39%
ROE 5.01%
ROIC 4.71%
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
SRT.DE Yearly ROA, ROE, ROICSRT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • SRT's Profit Margin of 3.80% is on the low side compared to the rest of the industry. SRT is outperformed by 72.22% of its industry peers.
  • SRT's Profit Margin has declined in the last couple of years.
  • SRT has a Operating Margin (14.06%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of SRT has declined.
  • With a decent Gross Margin value of 46.48%, SRT is doing good in the industry, outperforming 72.22% of the companies in the same industry.
  • SRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.06%
PM (TTM) 3.8%
GM 46.48%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
SRT.DE Yearly Profit, Operating, Gross MarginsSRT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • SRT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for SRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SRT.DE Yearly Shares OutstandingSRT.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SRT.DE Yearly Total Debt VS Total AssetsSRT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • SRT has an Altman-Z score of 2.10. This is not the best score and indicates that SRT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.10, SRT perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
  • The Debt to FCF ratio of SRT is 8.92, which is on the high side as it means it would take SRT, 8.92 years of fcf income to pay off all of its debts.
  • SRT's Debt to FCF ratio of 8.92 is on the low side compared to the rest of the industry. SRT is outperformed by 61.11% of its industry peers.
  • SRT has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
  • SRT has a worse Debt to Equity ratio (1.28) than 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 8.92
Altman-Z 2.1
ROIC/WACC0.58
WACC8.17%
SRT.DE Yearly LT Debt VS Equity VS FCFSRT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 0.95 indicates that SRT may have some problems paying its short term obligations.
  • The Current ratio of SRT (0.95) is worse than 77.78% of its industry peers.
  • A Quick Ratio of 0.49 indicates that SRT may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.49, SRT is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.49
SRT.DE Yearly Current Assets VS Current LiabilitesSRT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • Measured over the past 5 years, SRT shows a small growth in Earnings Per Share. The EPS has been growing by 1.76% on average per year.
EPS 1Y (TTM)N/A
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%21.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.97% on average over the next years. This is quite good.
  • SRT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.70% yearly.
EPS Next Y26.59%
EPS Next 2Y23.47%
EPS Next 3Y20.79%
EPS Next 5Y15.97%
Revenue Next Year8.17%
Revenue Next 2Y10.45%
Revenue Next 3Y10.04%
Revenue Next 5Y8.7%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SRT.DE Yearly Revenue VS EstimatesSRT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
SRT.DE Yearly EPS VS EstimatesSRT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 40.06, which means the current valuation is very expensive for SRT.
  • Compared to the rest of the industry, the Price/Earnings ratio of SRT indicates a slightly more expensive valuation: SRT is more expensive than 72.22% of the companies listed in the same industry.
  • SRT is valuated rather expensively when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
  • SRT is valuated quite expensively with a Price/Forward Earnings ratio of 31.65.
  • Based on the Price/Forward Earnings ratio, SRT is valued a bit more expensive than the industry average as 61.11% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.16, SRT is valued at the same level.
Industry RankSector Rank
PE 40.06
Fwd PE 31.65
SRT.DE Price Earnings VS Forward Price EarningsSRT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • SRT's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, SRT is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 29.96
EV/EBITDA 19.53
SRT.DE Per share dataSRT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as SRT's earnings are expected to grow with 20.79% in the coming years.
PEG (NY)1.51
PEG (5Y)22.72
EPS Next 2Y23.47%
EPS Next 3Y20.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.41%, SRT is not a good candidate for dividend investing.
  • SRT's Dividend Yield is comparable with the industry average which is at 0.45.
  • Compared to an average S&P500 Dividend Yield of 1.85, SRT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.41%

5.2 History

  • The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
SRT.DE Yearly Dividends per shareSRT.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • SRT pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
  • SRT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y23.47%
EPS Next 3Y20.79%
SRT.DE Yearly Income VS Free CF VS DividendSRT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SRT.DE Dividend Payout.SRT.DE Dividend Payout, showing the Payout Ratio.SRT.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SARTORIUS AG

FRA:SRT (2/19/2026, 9:54:52 AM)

191.5

+1.5 (+0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-03
Earnings (Next)04-23
Inst Owners4.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.34B
Revenue(TTM)N/A
Net Income(TTM)133.70M
Analysts80
Price Target302.69 (58.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.41%
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.41%
PT rev (3m)12.41%
EPS NQ rev (1m)-3.33%
EPS NQ rev (3m)-3.33%
EPS NY rev (1m)0.42%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-0.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 40.06
Fwd PE 31.65
P/S 4.08
P/FCF 29.96
P/OCF 16.4
P/B 5.37
P/tB N/A
EV/EBITDA 19.53
EPS(TTM)4.78
EY2.5%
EPS(NY)6.05
Fwd EY3.16%
FCF(TTM)6.39
FCFY3.34%
OCF(TTM)11.68
OCFY6.1%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)1.51
PEG (5Y)22.72
Graham Number61.91
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 5.01%
ROCE 6.33%
ROIC 4.71%
ROICexc 4.98%
ROICexgc 17.77%
OM 14.06%
PM (TTM) 3.8%
GM 46.48%
FCFM 13.61%
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 8.92
Debt/EBITDA 3.69
Cap/Depr 92.32%
Cap/Sales 11.25%
Interest Coverage 2.65
Cash Conversion 94.72%
Profit Quality 357.97%
Current Ratio 0.95
Quick Ratio 0.49
Altman-Z 2.1
F-Score7
WACC8.17%
ROIC/WACC0.58
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%21.15%
EPS Next Y26.59%
EPS Next 2Y23.47%
EPS Next 3Y20.79%
EPS Next 5Y15.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.29%
Revenue Next Year8.17%
Revenue Next 2Y10.45%
Revenue Next 3Y10.04%
Revenue Next 5Y8.7%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.42%
EBIT Next 3Y38.38%
EBIT Next 5Y25.33%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%

SARTORIUS AG / SRT.DE FAQ

What is the ChartMill fundamental rating of SARTORIUS AG (SRT.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SRT.DE.


What is the valuation status of SARTORIUS AG (SRT.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to SARTORIUS AG (SRT.DE). This can be considered as Overvalued.


How profitable is SARTORIUS AG (SRT.DE) stock?

SARTORIUS AG (SRT.DE) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for SRT stock?

The Price/Earnings (PE) ratio for SARTORIUS AG (SRT.DE) is 40.06 and the Price/Book (PB) ratio is 5.37.


What is the expected EPS growth for SARTORIUS AG (SRT.DE) stock?

The Earnings per Share (EPS) of SARTORIUS AG (SRT.DE) is expected to grow by 26.59% in the next year.